Epigenetic age acceleration and methylation differences in IgG4-related cholangitis and primary sclerosing cholangitis.
Noble A. et al, (2025), Clin Epigenetics, 17
Evaluation of intestinal biopsy tissue preservation methods to facilitate large-scale mucosal microbiota research.
Wyatt NJ. et al, (2024), EBioMedicine, 112
Cytokine signature in convalescent SARS-CoV-2 patients with inflammatory bowel disease receiving vedolizumab
Dallari S. et al, (2024), Scientific Reports, 14
Exposure to air pollution increases susceptibility to ulcerative colitis through epigenetic alterations in CXCR2 and MHC class III region.
Chen J. et al, (2024), EBioMedicine, 110
The circulating methylome in childhood-onset inflammatory bowel disease.
Noble A. et al, (2024), J Crohns Colitis
Prenatal cannabis exposure is associated with alterations in offspring DNA methylation at genes involved in neurodevelopment, across the life course.
Noble AJ. et al, (2024), Mol Psychiatry
Intestinal Inflammation and Extraintestinal Disease: Understanding Dynamic Risk.
Ashton JJ. et al, (2024), Gastroenterology, 167, 205 - 208
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial.
Satsangi J. et al, (2024), Lancet Gastroenterol Hepatol, 9, 591 - 592
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource.
Kapizioni C. et al, (2024), J Crohns Colitis, 18, 790 - 800
Identification and validation of a blood- based diagnostic lipidomic signature of pediatric inflammatory bowel disease.
Salihovic S. et al, (2024), Nat Commun, 15
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.
Goodyear CS. et al, (2024), Lancet Rheumatol, 6, e339 - e351
Challenges in IBD Research 2024: Precision Medicine.
Syed S. et al, (2024), Inflamm Bowel Dis, 30, S39 - S54
Arthritis complicating inflammatory bowel disease – the future is now
Song K. et al, (2024), The Lancet Rh
Antibody, not Cellular, Immune Responses to SARS-CoV-2 Vaccination Outperform Infection in Inflammatory Bowel Disease Patients.
González Cueto E. et al, (2024), Inflamm Bowel Dis, 30, 859 - 862
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial.
Lindsay JO. et al, (2024), Lancet Gastroenterol Hepatol, 9, 333 - 345
Sodium fluoride preserves blood metabolite integrity for biomarker discovery in large-scale, multi-site metabolomics investigations.
Xiong W. et al, (2024), Analyst, 149, 1238 - 1249
Altered DNA methylation within DNMT3A, AHRR, LTA/TNF loci mediates the effect of smoking on inflammatory bowel disease.
Zhang H. et al, (2024), Nat Commun, 15
Geography Influences Susceptibility to SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease: Multinational Analysis From the ICARUS-IBD Consortium.
Wong S-Y. et al, (2023), Inflamm Bowel Dis, 29, 1693 - 1705